LB Investment is a Seoul-based venture capital firm that focuses on early-stage investments, growth capital, mezzanine financing, and buyouts across diverse sectors. Their strategy targets industries such as biotech, life sciences, technology (including AI and semiconductors), healthcare, energy, consumer goods, and entertainment, primarily in South Korea and China, with some consideration for the US market.
Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-b (60% of deals). Average disclosed round size is $36.3M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$1.5B
Top Stage
Series B
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Jupiter Endovascular | Series B | $40M | Oct 2025 |
| IIllimis Therapeutics | Series B | $42M | Jul 2025 |
 Nota AI | Series C | $19.9M | Jun 2024 |
 Nota | Series B | $14.7M | Oct 2021 |
 HappyFresh | Series D | $65M | Jul 2021 |
Top Co-Investors
STIC Investment2 shared
InterVest2 shared
Z Venture Capital1 shared
DSC Investment1 shared
Aju IB1 shared
IMM Investment1 shared
GSR Ventures1 shared
Korea Development Bank1 shared
Mirae Asset Securities1 shared
Stonebridge1 shared
Last updated: 16 April 2026